Thomas Templeman

SVP, Pharmaceutical Operations, Medivation.

Companies

Centessa Pharmaceuticals plcChief Technology Officer May 27, 2021 to Apr 4, 2023¹
Nuvation Bio Inc.SVP, Pharmaceutical Ops Feb 12, 2021 to Feb 12, 2021²
MedivationSVP, Pharmaceutical Operations Oct 1, 2015 to Oct 1, 2015³

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 31, 2023Shares withheld for tax 4,103 shares at $3.90 of Centessa Pharmaceuticals plc⁴
Feb 1, 2023Granted 60,400 shares of Centessa Pharmaceuticals plc⁵
Dec 31, 2022Shares withheld for tax 2,921 shares at $3.10 of Centessa Pharmaceuticals plc⁶
Oct 3, 2022Sold 2,455 shares at $3.95 of Centessa Pharmaceuticals plc⁷
Sep 30, 2022Sold 2,003 shares at $4.07 of Centessa Pharmaceuticals plc⁷
Sep 30, 2022Shares withheld for tax 5,382 shares at $4.25 of Centessa Pharmaceuticals plc⁸
Jul 1, 2022Granted 140,000 shares of Centessa Pharmaceuticals plc⁹

The numbers on this page point here. Each one links to the record it came from.